Tag Archives: Sumant Kulkarni
Analysts Are Bullish on These Healthcare Stocks: Zynerba Pharmaceuticals (ZYNE), Beyondspring (BYSI)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Zynerba Pharmaceuticals (ZYNE – Research Report) and Beyondspring (BYSI – Research Report) with bullish sentiments. Zynerba Pharmaceuticals (ZYNE) In a report issued
Voyager Therapeutics (VYGR) Receives a Buy from Canaccord Genuity
In a report issued on December 22, Sumant Kulkarni from Canaccord Genuity maintained a Buy rating on Voyager Therapeutics (VYGR – Research Report), with a price target of $14.00. The company’s shares closed last Tuesday at $8.69. According to TipRanks.com,
Analysts Offer Insights on Healthcare Companies: Intra-Cellular Therapies (NASDAQ: ITCI) and Ascendis Pharma (NASDAQ: ASND)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Intra-Cellular Therapies (ITCI – Research Report) and Ascendis Pharma (ASND – Research Report) with bullish sentiments. Intra-Cellular Therapies (ITCI) In a report
Analysts Are Bullish on Top Healthcare Stocks: Biogen (BIIB)
There’s a lot to be optimistic about in the Healthcare sector as 1 analysts just weighed in on and Biogen (BIIB – Research Report) with bullish sentiments. Biogen (BIIB) Canaccord Genuity analyst Sumant Kulkarni maintained a Buy rating on Biogen
Analysts Offer Insights on Healthcare Companies: Bioxcel Therapeutics (NASDAQ: BTAI) and InMode (NASDAQ: INMD)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Bioxcel Therapeutics (BTAI – Research Report) and InMode (INMD – Research Report) with bullish sentiments. Bioxcel Therapeutics (BTAI) In a report released
Intra-Cellular Therapies (ITCI) Gets a Buy Rating from Canaccord Genuity
In a report released yesterday, Sumant Kulkarni from Canaccord Genuity maintained a Buy rating on Intra-Cellular Therapies (ITCI – Research Report), with a price target of $70.00. The company’s shares closed last Monday at $19.46. According to TipRanks.com, Kulkarni is
